STAT+: Omada reports first profitable quarter as it seizes broad GLP-1 opportunity
Digital chronic care company Omada reported a quarterly profit for the first time since going public less than a year ago, the company revealed while announcing its full year 2025 earnings Thursday.
Omada also provided earnings guidance for 2026, suggesting the company will continue to grow as it capitalizes on the demand for popular GLP-1 obesity medications.
Omada earned $260 million in revenue in 2025, 53% more than the year before — above top-end preliminary results the company announced at the J.P. Morgan Healthcare Conference in January. In August, shortly after it went public, it projected top-end earnings of $241 million for the year.
Mario Aguilar
Go to statnews